Recently conducted research has demonstrated that temozolomide can hinder malignant glioma progression by suppressing AQP4 expressions, and suggests this could potentially lead to the discovery of novel therapeutic strategies for GBM [15]. Here, AQP4 is linked to malignant glioma.